Status:
COMPLETED
Buprenorphine Maintenance Protocol - 1
Lead Sponsor:
University of California, Los Angeles
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Opioid-Related Disorders
Eligibility:
All Genders
21-50 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to compare the efficacy of buprenorphine versus methadone.
Eligibility Criteria
Inclusion Criteria:
M/F ages 21-50. Opiate dependence according to DSM-IV criteria. Self-reported use within the last 30 days. Agreeable to conditions of study and signed informed consent.
Exclusion Criteria:
Psychiatric disorder that requires medication therapy. History of seizures. Pregnant and /or nursing women. Dependence on ETOH or benzodiazepines or other sedative/hynotics. Acute hepatitis. Other medical conditions that deem participation to be unsafe
Key Trial Info
Start Date :
October 1 1990
Trial Type :
INTERVENTIONAL
End Date :
September 1 1993
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00000205
Start Date
October 1 1990
End Date
September 1 1993
Last Update
July 11 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Friends Research Institute
Los Angeles, California, United States, 90025